What is a stock summary page? Click here for an overview.
Business Description
New Ray Medicine International Holding Ltd
ISIN : BMG647461117
Compare
Compare
Traded in other countries / regions
06108.Hong Kong IPO Date
2013-10-25Description
New Ray Medicine International Holding Ltd is engaged in the trading and distribution of pharmaceutical products in the People's Republic of China. The company's segments include the Distribution and trading of pharmaceutical products and the Provision of marketing and promotion services. Distribution and trading of pharmaceutical products consist of Injection drugs and generate a majority of revenue for the company.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 18.11 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.11 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 4.5 | |||||
| Beneish M-Score | -2.95 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -27.9 | |||||
| 3-Year EBITDA Growth Rate | 35.9 | |||||
| 3-Year EPS without NRI Growth Rate | -38.7 | |||||
| 3-Year FCF Growth Rate | -12.4 | |||||
| 3-Year Book Growth Rate | -7.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.4 | |||||
| 9-Day RSI | 39.81 | |||||
| 14-Day RSI | 44.15 | |||||
| 3-1 Month Momentum % | -8.51 | |||||
| 6-1 Month Momentum % | -8.51 | |||||
| 12-1 Month Momentum % | 13.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 12.01 | |||||
| Quick Ratio | 11.27 | |||||
| Cash Ratio | 2.35 | |||||
| Days Inventory | 105.89 | |||||
| Days Sales Outstanding | 320.85 | |||||
| Days Payable | 56.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 0.78 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 12.23 | |||||
| Operating Margin % | -20.34 | |||||
| Net Margin % | -33.01 | |||||
| FCF Margin % | -13.23 | |||||
| ROE % | -6.55 | |||||
| ROA % | -6.24 | |||||
| ROIC % | -4.63 | |||||
| 3-Year ROIIC % | -0.58 | |||||
| ROC (Joel Greenblatt) % | -11.37 | |||||
| ROCE % | -6.67 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.77 | |||||
| PB Ratio | 0.15 | |||||
| Price-to-Tangible-Book | 0.15 | |||||
| EV-to-EBIT | -0.35 | |||||
| EV-to-EBITDA | -0.35 | |||||
| EV-to-Revenue | 0.12 | |||||
| EV-to-FCF | -1.03 | |||||
| Price-to-GF-Value | 1.43 | |||||
| Price-to-Projected-FCF | 2.15 | |||||
| Price-to-Median-PS-Value | 0.72 | |||||
| Price-to-Net-Current-Asset-Value | 0.24 | |||||
| Price-to-Net-Cash | 2.15 | |||||
| Earnings Yield (Greenblatt) % | -285.71 | |||||
| FCF Yield % | -17.29 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
New Ray Medicine International Holding Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 93.945 | ||
| EPS (TTM) (HK$) | -0.018 | ||
| Beta | -0.68 | ||
| 3-Year Sharpe Ratio | 0.39 | ||
| 3-Year Sortino Ratio | 2.76 | ||
| Volatility % | 64.31 | ||
| 14-Day RSI | 44.15 | ||
| 14-Day ATR (HK$) | 0.003855 | ||
| 20-Day SMA (HK$) | 0.04705 | ||
| 12-1 Month Momentum % | 13.16 | ||
| 52-Week Range (HK$) | 0.033 - 0.084 | ||
| Shares Outstanding (Mil) | 1,671.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
New Ray Medicine International Holding Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
New Ray Medicine International Holding Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
New Ray Medicine International Holding Ltd Frequently Asked Questions
What is New Ray Medicine International Holding Ltd(HKSE:06108)'s stock price today?
The current price of HKSE:06108 is HK$0.04. The 52 week high of HKSE:06108 is HK$0.08 and 52 week low is HK$0.03.
When is next earnings date of New Ray Medicine International Holding Ltd(HKSE:06108)?
The next earnings date of New Ray Medicine International Holding Ltd(HKSE:06108) is .
Does New Ray Medicine International Holding Ltd(HKSE:06108) pay dividends? If so, how much?
New Ray Medicine International Holding Ltd(HKSE:06108) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers